HIV And HCV infection among opiate-dependent patients and methadone doses: the PROTEUS study

References

• Bao, Y. P., Liu, Z. M., Epstein, D. H., Du, C., Shi, J., & Lu, L. (2009). A meta-analysis of retention in methadone maintenance by dose and dosing strategy. The American Journal of Drug and Alcohol Abuse, 35(1), 28–33. doi:10.1080/00952990802342899
   PubMed Web of Science ®Google Scholar
• Berg, K. M., Litwin, A., Li, X., Heo, M., & Arnsten, J. H. (2011). Directly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: A randomized controlled trial. Drug and Alcohol Dependence, 113(2-3), 192–199. doi:10.1016/j.drugalcdep.2010.07.025
   PubMed Web of Science ®Google Scholar
• Beyrer, C., Malinowska-Sempruch, K., Kamarulzaman, A., Kazatchkine, M., Sidibe, M., & Strathdee, S. A. (2010). Time to act: A call for comprehensive responses to HIV in people who use drugs. The Lancet, 376(9740), 551–563. doi:10.1016/S0140-6736(10)60928-2
   PubMed Web of Science ®Google Scholar
• Clarke, S. M., Mulcahy, F. M., Tjia, J., Reynolds, H. E., Gibbons, S. E., Barry, M. G., & Back, D. J. (2001). Pharmacokinetic interactions of nevirapine and methadone and guidelines for use of nevirapine to treat injection drug users. Clinical Infectious Diseases, 33(9), 1595–1597. doi:10.1086/322519
   PubMed Web of Science ®Google Scholar
• Dimova, R. B., Zeremski, M., Jacobson, I. M., Hagan, H., Des Jarlais, D. C., & Talal, A. H. (2013). Determinants of hepatitis C virus treatment completion and efficacy in drug users assessed by meta-analysis. Clinical Infectious Diseases, 56(6), 806–816. doi:10.1093/cid/cis1007
   PubMed Web of Science ®Google Scholar
• Esteban, J. I., Sauleda, S., & Quer, J. (2008). The changing epidemiology of hepatitis C virus infection in Europe. Journal of Hepatology, 48(1), 148–162. doi:10.1016/j.jhep.2007.07.033
   PubMed Web of Science ®Google Scholar
• Garimella, T., Wang, R., Luo, W. L., Wastall, P., Kandoussi, H., DeMicco, M., … Bifano, M. (2015). Assessment of drug-drug interactions between daclatasvir and methadone or buprenorphine-naloxone. Antimicrobial Agents and Chemotherapy, 59(9), 5503–5510. doi:10.1128/AAC.00478-15
   PubMed Web of Science ®Google Scholar
• Hagan, H., Pouget, E. R., & Des Jarlais, D. C. (2011). A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs. Journal of Infectious Diseases, 204(1), 74–83. doi:10.1093/infdis/jir196
   PubMed Web of Science ®Google Scholar
• Joseph, B., Kerr, T., Puskas, C. M., Montaner, J., Wood, E., & Milloy, M. J. (2015). Factors linked to transitions in adherence to antiretroviral therapy among HIV-infected illicit drug users in a Canadian setting. AIDS Care, 27(9), 1128–1136. doi:10.1080/09540121.2015.1032205
   PubMed Web of Science ®Google Scholar
• Korthuis, P. T., Fiellin, D. A., Fu, R., Lum, P. J., Altice, F. L., Sohler, N., … McCarty, D. (2011). Improving adherence to HIV quality of care indicators in persons with opioid dependence: The role of buprenorphine. JAIDS Journal of Acquired Immune Deficiency Syndromes, 56(Suppl. 1), S83–90. doi:10.1097/QAI.0b013e31820bc9a5
   PubMed Web of Science ®Google Scholar
• Lappalainen, L., Nolan, S., Dobrer, S., Puscas, C., Montaner, J., Ahamad, K., … Milloy, M.-J. (2015). Dose-response relationship between methadone dose and adherence to antiretroviral therapy among HIV-positive people who use illicit opioids. Addiction, 110(8), 1330–1339. doi:10.1111/add.12970
   PubMed Web of Science ®Google Scholar
• Lin, C. K., Hung, C. C., Peng, C. Y., Chao, E., & Lee, T. S. (2015). Factors associated with methadone treatment duration: A Cox regression analysis. PLoS One, 10(4), e0123687. doi:10.1371/journal.pone.0123687
   PubMed Web of Science ®Google Scholar
• MacArthur, G. J., Minozzi, S., Martin, N., Vickerman, P., Deren, S., Bruneau, J., … Hickman, M. (2012). Opiate substitution treatment and HIV transmission in people who inject drugs: Systematic review and meta-analysis. BMJ, 345, e5945. doi:10.1136/bmj.e5945
   PubMed Web of Science ®Google Scholar
• Marotta, P. L., & McCullagh, C. A. (2016). A cross-national analysis of the effects of methadone maintenance and needle and syringe program implementation on incidence rates of HIV in Europe from 1995 to 2011. International Journal of Drug Policy, 32, 3–10. doi:10.1016/j.drugpo.2016.02.007
   PubMed Web of Science ®Google Scholar
• Marzolini, C., Troillet, N., Telenti, A., Baumann, P., Decosterd, L. A., & Eap, C. B. (2000). Efavirenz decreases methadone blood concentrations. AIDS, 14(9), 1291–1292. doi: 10.1097/00002030-200006160-00036
   PubMed Web of Science ®Google Scholar
• Mason, J. W. (2013). Editorial commentary: The methadone menace. Clinical Infectious Diseases, 57(8), 1195–1196. doi:10.1093/cid/cit469
   PubMed Web of Science ®Google Scholar
• Mouly, S., Bloch, V., Peoc'h, K., Houze, P., Labat, L., Ksouda, K., … Vorspan, F. (2015). Methadone dose in heroin-dependent patients: Role of clinical factors, comedications, genetic polymorphisms and enzyme activity. British Journal of Clinical Pharmacology, 79(6), 967–977. doi:10.1111/bcp.12576
   PubMed Web of Science ®Google Scholar
• Nelson, P. K., Mathers, B. M., Cowie, B., Hagan, H., Des Jarlais, D., Horyniak, D., & Degenhardt, L. (2011). Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: Results of systematic reviews. The Lancet, 378(9791), 571–583. doi:10.1016/S0140-6736(11)61097-0
   PubMed Web of Science ®Google Scholar
• Nolan, S., Dias Lima, V., Fairbairn, N., Kerr, T., Montaner, J., Grebely, J., & Wood, E. (2014). The impact of methadone maintenance therapy on heptatis c incidence among illicit drug users. Addiction, 109(12), 2053–2059. doi:10.1111/add.12682
   PubMed Web of Science ®Google Scholar
• Nosyk, B., Min, J. E., Colley, G., Lima, V. D., Yip, B., Milloy, M.-J. S., … Montaner, J. S. G. (2015). The causal effect of opioid substitution treatment on HAART medication refill adherence. AIDS, 29(8), 965–973. doi:10.1097/QAD.0000000000000642
   PubMed Web of Science ®Google Scholar
• Rodríguez-Arrondo, F., Aguirrebengoa, K., Portu, J., Muñoz, J., García, M. A., Goikoetxea, J., … Clotet, B. (2009). Long-term effectiveness and safety outcomes in HIV-1-infected patients after a median time of 6 years on nevirapine. Current HIV Research, 7(5), 526–532. doi: 10.2174/157016209789346246
   PubMed Web of Science ®Google Scholar
• Roncero, C., Barral, C., Rodríguez-Cintas, L., Pérez-Pazos, J., Martinez-Luna, N., Casas, M., … Grau-López, L. (2016). Psychiatric comorbidities in opioid-dependent patients undergoing a replacement therapy programme in Spain: The PROTEUS study. Psychiatry Research, 243, 174–181. doi:10.1016/j.psychres.2016.06.024
   PubMed Web of Science ®Google Scholar
• Roncero, C., Fuste, G., Barral, C., Rodríguez-Cintas, L., Martínez-Luna, N., Eiroa-Orosa, F. J. , … Investigators, on behalf of the PROTEUS study. (2011). Therapeutic management and comorbidities in opiate-dependent patients undergoing a replacement therapy programme in Spain: The PROTEUS study. Heroin Addiction and Related Clinical Problems, 13(3), 5–16.
   Web of Science ®Google Scholar
• Roncero, C., Álvarez, F.J., Barral, C., Gómez-Baeza, S., Gonzalvo, B., Rodríguez-Cintas, L. , … PROTEUS study investigators. (2013). Driving and legal status of Spanish opioid-dependent patients. Substance Abuse Treatment, Prevention, and Policy, 8, 19. doi:10.1186/1747-597X-8-19
   PubMed Web of Science ®Google Scholar
• Roux, P., Carrieri, M. P., Cohen, J., Ravaux, I., Poizot-Martin, I., Dellamonica, P., & Spire, B. (2009). Retention in opioid substitution treatment: A major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment. Clinical Infectious Diseases, 49(9), 1433–1440. doi:10.1086/630209
   PubMed Web of Science ®Google Scholar
• Sanvisens, A., Rivas, I., Faure, E., Munoz, T., Rubio, M., Fuster, D., … Muga, R. (2014). [Characteristics of heroin dependent patients admitted to a methadone treatment program]. Medicina Clínica, 142(2), 53–58. doi:10.1016/j.medcli.2012.10.023
   PubMed Web of Science ®Google Scholar
• Springer, S. A., Qiu, J., Saber-Tehrani, A. S., & Altice, F. L. (2012). Retention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisoners. PLoS One, 7(5), e38335. doi: 10.1371/journal.pone.0038335
   PubMed Web of Science ®Google Scholar
• Taylor, L. E., Maynard, M. A., Friedmann, P. D., Macleod, C. J., Rich, J. D., Flanigan, T. P., & Sylvestre, D. L. (2012). Buprenorphine for human immunodeficiency virus/hepatitis C virus-coinfected patients: Does it serve as a bridge to hepatitis C virus therapy? Journal of Addiction Medicine, 6(3), 179–185. doi:10.1097/ADM.0b013e318257377f
   PubMed Web of Science ®Google Scholar
• UNODC. (2015). World Drug Report (United Nations publication, Sales No. E.12.XI.1).
   Google Scholar
• Wei, X., Wang, L., Wang, X., Li, J., Li, H., & Jia, W. (2013). A study of 6-year retention in methadone maintenance treatment among opioid-dependent patients in Xi'an. Journal of Addiction Medicine, 7(5), 342–348. doi: 10.1097/ADM.0b013e31829da05b
   PubMed Web of Science ®Google Scholar
• Westergaard, R. P., Hess, T., Astemborski, J., Mehta, S. H., & Kirk, G. D. (2013). Longitudinal changes in engagement in care and viral suppression for HIV-infected injection drug users. AIDS, 27(16), 2559–2566. doi:10.1097/QAD.0b013e328363bff2
   PubMed Web of Science ®Google Scholar
• Wickersham, J. A., Zahari, M. M., Azar, M. M., Kamarulzaman, A., & Altice, F. L. (2013). Methadone dose at the time of release from prison significantly influences retention in treatment: Implications from a pilot study of HIV-infected prisoners transitioning to the community in Malaysia. Drug and Alcohol Dependence, 132(1-2), 378–382. doi:10.1016/j.drugalcdep.2013.01.005
   PubMed Web of Science ®Google Scholar
• Xiaoli, W., Lirong, W., Xueliang, W., Jinsong, L., Hengxin, L., & Wei, J. (2014). Risk factors of hepatitis C virus infection in drug users from eleven methadone maintenance treatment clinics in Xi'an, China. Hepatitis Monthly, 14(11), e19601. doi:10.5812/hepatmon.19601
   PubMed Web of Science ®Google Scholar
• Zhou, K., & Zhuang, G. (2014). Retention in methadone maintenance treatment in mainland China, 2004-2012: A literature review. Addictive Behaviors, 39(1), 22–29. doi:10.1016/j.addbeh.2013.09.001
   PubMed Web of Science ®Google Scholar